To gain insight into how the expression of CYP2E1 was altered in lung cancer, we quantified the level of CYP2E1 in the peritumoral tissues of non‐small cell lung cancer (NSCLC) patients. This evidence concerns the gene CYP2E1 and non-small cell lung carcinoma.